TTP 355Alternative Names: TTP355
Latest Information Update: 24 Jul 2013
At a glance
- Originator TransTech Pharma
- Class Antihyperglycaemics; Small molecules
- Mechanism of Action Glucokinase stimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Type 2 diabetes mellitus